YBX1 and plasma cell myeloma: Together, these results recapitulated and validated the gene expression patterns observed in our scRNA-seq analysis, and suggested that YBX1 facilitated its impacts on myeloma survival and drug response by affecting T cells function and promoting immune suppression.